nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—Hepatitis acute—Methotrexate—ankylosing spondylitis	0.0515	0.0515	CcSEcCtD
Cefdinir—Allergic cutaneous angiitis—Methotrexate—ankylosing spondylitis	0.0235	0.0235	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.0184	0.0184	CcSEcCtD
Cefdinir—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Cefdinir—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Cefdinir—Nephropathy—Methotrexate—ankylosing spondylitis	0.0157	0.0157	CcSEcCtD
Cefdinir—Interstitial pneumonia—Methotrexate—ankylosing spondylitis	0.0155	0.0155	CcSEcCtD
Cefdinir—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Cefdinir—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.0152	0.0152	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisone—ankylosing spondylitis	0.0134	0.0134	CcSEcCtD
Cefdinir—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Cefdinir—Candida infection—Triamcinolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Cefdinir—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.0106	0.0106	CcSEcCtD
Cefdinir—Purpura—Triamcinolone—ankylosing spondylitis	0.00853	0.00853	CcSEcCtD
Cefdinir—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.0084	0.0084	CcSEcCtD
Cefdinir—Hyperkinesia—Prednisone—ankylosing spondylitis	0.0078	0.0078	CcSEcCtD
Cefdinir—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Cefdinir—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Cefdinir—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00748	0.00748	CcSEcCtD
Cefdinir—Melaena—Methotrexate—ankylosing spondylitis	0.0073	0.0073	CcSEcCtD
Cefdinir—Asthma—Triamcinolone—ankylosing spondylitis	0.0071	0.0071	CcSEcCtD
Cefdinir—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00706	0.00706	CcSEcCtD
Cefdinir—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00702	0.00702	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00679	0.00679	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00675	0.00675	CcSEcCtD
Cefdinir—Purpura—Prednisone—ankylosing spondylitis	0.00674	0.00674	CcSEcCtD
Cefdinir—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00669	0.00669	CcSEcCtD
Cefdinir—Cardiac failure—Prednisone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Cefdinir—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00624	0.00624	CcSEcCtD
Cefdinir—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00623	0.00623	CcSEcCtD
Cefdinir—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Cefdinir—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Cefdinir—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Cefdinir—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00618	0.00618	CcSEcCtD
Cefdinir—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Cefdinir—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00604	0.00604	CcSEcCtD
Cefdinir—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00588	0.00588	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.00575	0.00575	CcSEcCtD
Cefdinir—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Cefdinir—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.0057	0.0057	CcSEcCtD
Cefdinir—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00569	0.00569	CcSEcCtD
Cefdinir—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Cefdinir—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Cefdinir—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Cefdinir—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Cefdinir—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Cefdinir—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Cefdinir—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Cefdinir—Neutropenia—Prednisone—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Cefdinir—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Cefdinir—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Cefdinir—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Cefdinir—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00473	0.00473	CcSEcCtD
Cefdinir—Asthma—Methotrexate—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Cefdinir—Convulsion—Prednisolone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Cefdinir—Hypertension—Prednisolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Cefdinir—Haemoglobin—Prednisone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Cefdinir—Haemorrhage—Prednisone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Cefdinir—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Cefdinir—Neutropenia—Methotrexate—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Cefdinir—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Cefdinir—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Cefdinir—Shock—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Cefdinir—Convulsion—Triamcinolone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Cefdinir—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Cefdinir—Hypertension—Triamcinolone—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Cefdinir—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Cefdinir—Pneumonia—Methotrexate—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Cefdinir—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Cefdinir—Renal failure—Methotrexate—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Cefdinir—Stomatitis—Methotrexate—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cefdinir—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Cefdinir—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Cefdinir—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Cefdinir—Haematuria—Methotrexate—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Cefdinir—Shock—Triamcinolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Cefdinir—Insomnia—Prednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Cefdinir—Shock—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Cefdinir—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Cefdinir—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Cefdinir—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Cefdinir—Convulsion—Betamethasone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Cefdinir—Convulsion—Dexamethasone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Cefdinir—Hypertension—Betamethasone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Cefdinir—Hypertension—Dexamethasone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Cefdinir—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Cefdinir—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Cefdinir—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Cefdinir—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Cefdinir—Insomnia—Triamcinolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Cefdinir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Cefdinir—Shock—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Cefdinir—Shock—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Cefdinir—Agitation—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Cefdinir—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Cefdinir—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Cefdinir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Cefdinir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Cefdinir—Anorexia—Dexamethasone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Cefdinir—Anorexia—Betamethasone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Cefdinir—Convulsion—Prednisone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Cefdinir—Hypertension—Prednisone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Cefdinir—Insomnia—Dexamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cefdinir—Insomnia—Betamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Cefdinir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Cefdinir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Cefdinir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Cefdinir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Cefdinir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Cefdinir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefdinir—Shock—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Cefdinir—Anorexia—Prednisone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Cefdinir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Cefdinir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Cefdinir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Cefdinir—Dizziness—Prednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Asthenia—Triamcinolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefdinir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Cefdinir—Insomnia—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Cefdinir—Pruritus—Triamcinolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Cefdinir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Cefdinir—Dyspepsia—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Cefdinir—Decreased appetite—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Cefdinir—Rash—Prednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Cefdinir—Dermatitis—Prednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Cefdinir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefdinir—Headache—Prednisolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Cefdinir—Constipation—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Cefdinir—Dizziness—Triamcinolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Cefdinir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Cefdinir—Asthenia—Betamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefdinir—Asthenia—Dexamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefdinir—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefdinir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefdinir—Nausea—Prednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefdinir—Pruritus—Dexamethasone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Cefdinir—Pruritus—Betamethasone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Cefdinir—Vomiting—Triamcinolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Cefdinir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Cefdinir—Rash—Triamcinolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Cefdinir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefdinir—Rash—Methylprednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefdinir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefdinir—Headache—Triamcinolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefdinir—Headache—Methylprednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefdinir—Abdominal pain—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefdinir—Body temperature increased—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefdinir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefdinir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefdinir—Dizziness—Dexamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefdinir—Dizziness—Betamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefdinir—Insomnia—Methotrexate—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefdinir—Nausea—Triamcinolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Cefdinir—Nausea—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefdinir—Somnolence—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefdinir—Vomiting—Betamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Cefdinir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Cefdinir—Rash—Betamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefdinir—Rash—Dexamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefdinir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefdinir—Dermatitis—Betamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefdinir—Headache—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefdinir—Headache—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefdinir—Asthenia—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefdinir—Pruritus—Prednisone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefdinir—Diarrhoea—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefdinir—Nausea—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefdinir—Nausea—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefdinir—Dizziness—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Cefdinir—Vomiting—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefdinir—Rash—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefdinir—Dermatitis—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefdinir—Headache—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefdinir—Asthenia—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefdinir—Nausea—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefdinir—Pruritus—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefdinir—Dizziness—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefdinir—Rash—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefdinir—Headache—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Cefdinir—Nausea—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
